Industry news that matters to you.  Learn more

New Nanotechnology Detects Biomarkers of Cancer

Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.

Shrink Wrap Used to Enhance Detection of Infectious Disease Biomarkers

Detecting HIV/AIDS, tuberculosis, malaria and other deadly infectious diseases as early as possible helps to prevent their rapid spread and allows for more effective treatments. But current detection methods are cost-prohibitive in most areas of the world. Now a new nanotechnology method—employing common, everyday shrink wrap—may make highly sensitive, extremely low-cost diagnosis of infectious disease agents possible.

Nanomix Initiates Clinical Testing of Point of Care IVD Cardiac Panel

Nanōmix Inc., (Nanōmix), a leading nanotechnology company focused on development of next generation point of care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, recently announced that it has initiated clinical testing in the U.S. to evaluate the Omega 3 Cardiac Panel.

The Scientist Webinar: Tackling the Challenges Involved with Protein Biomarkers

Protein biomarkers have been hailed as vital stepping stones in the race to personalize medicine. But many hurdles remain to be cleared before their application becomes routine. Currently, protein biomarkers have proven useful in drug discovery and development, as tools for target discovery and evaluation of a drug’s mechanism of action, and in therapies for prevention, early detection, diagnosis, and treatment of disease. Although single markers are in use, more widespread adoption will probably require a multiplexed panel capable of detecting and measuring biomarkers accurately, inexpensively, and easily in biological samples that are highly complex.

Quantum Dots Provide Quantitative Profile of Pancreatic Cancer Biomarkers on Single Cells

With the aid of a novel set of lipid-coated, targeted quantum dots, researchers at Johns Hopkins University have developed a method for quantifying multiple specific biomarkers on the surfaces of individual cancer cells. This approach to quantitative biomarker detection stands to improve the histopathology methods used to diagnosis pancreatic and other cancers and enable the development of methods to spot cancer cells circulating in the blood stream.